SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience -- Ignore unavailable to you. Want to Upgrade?

To: Craig S. Owens who wrote (389)4/22/1998 6:44:00 PM
From: TheSlowLane  Read Replies (1) | Respond to of 675
 
What is it that you like about this stock? An article I read in the WSJ yesterday discussed some developments that are going to obsolete GGF's before they get out of the lab. The COX-2 products being brought to market by Monsanto next year will probably put the kabosh on CNSI's efforts towards a pain drug...so much for CNSI's pipeline. Sure, it's cheap. What besides that is there to like? I've got 2700 shares I'll sell you for $6/each...



To: Craig S. Owens who wrote (389)4/22/1998 6:48:00 PM
From: BRSteve  Read Replies (1) | Respond to of 675
 
Thanks for the feedback. I called CNSI today and talked to the CFO. He was in meetings this morning. He talked about selling corp. assets, with the proceeds going to the shareholders. We also talked about a possible merger. He told me whatever they are doing will take about 30 days. I guess its up to us whether or not we want to wait and see. Again, thanks, BRSteve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News